Marksans Pharma Stock Soars to New High, Outperforms Sector and Sensex
On November 26, 2024, Marksans Pharma's stock price increased by 7.13%, reaching a new 52-week and all-time high of Rs. 333.85. The company has outperformed the sector by 5.2% and has shown consistent strength, trading above its moving averages. It has also outperformed the Sensex by a significant margin, with a 'Hold' call from MarketsMojo.
Marksans Pharma, a midcap pharmaceutical company, has seen a significant increase in its stock price on November 26, 2024. The stock has gained 7.13% and is currently trading at a new 52-week and all-time high of Rs. 333.85. This performance has been recognized by MarketsMOJO, who have given a 'Hold' call for the stock.
In today's trading session, Marksans Pharma has outperformed the sector by 5.2%. This is the second consecutive day of gains for the stock, with a total increase of 8.35% in the past two days. The stock also touched an intraday high of Rs. 333.85, showing a 5.75% increase.
Marksans Pharma's performance has been consistently strong, as it is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.
In comparison to the overall market performance, Marksans Pharma has outperformed the Sensex by a significant margin. The stock's 1-day performance is 7.38% compared to the Sensex's 0.16%, and its 1-month performance is 29.00% compared to the Sensex's 1.05%.
Overall, Marksans Pharma's stock has shown a strong performance and is currently trading at a new high. With a 'Hold' call from MarketsMOJO, investors may want to keep an eye on this midcap pharmaceutical company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
